期刊
JOURNAL OF ENDOCRINOLOGY
卷 201, 期 3, 页码 309-320出版社
BIOSCIENTIFICA LTD
DOI: 10.1677/JOE-08-0568
关键词
-
资金
- GlaxoSmithKline Clinician Scientist Fellowship
- Arthritis Research Campaign [18081]
Chronic inflammatory diseases of almost any cause are associated with bone loss. Bone loss is due to direct effects of inflammation, poor nutrition, reduced lean body mass, immobility and the effects of treatments, especially glucocorticoids. These mechanisnis are complex and interrelated but are ultimately mediated through effects oil the bone remodelling cycle. Inflammatory disease call increase bone resorption, decrease bone formation but most commonly impacts on both of these processes resulting in all uncoupling of bone formation from resorption in favour of excess resorption. This review will illustrate these interactions between inflammation and bone metabolism and discuss how these are, and might be, manipulated as therapies for inflammation related bone loss. Journal of Endocrinology (2009) 201, 309-320
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据